Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

526.000
+104.20024.70%
Volume:117.82K
Turnover:58.33M
Market Cap:46.75B
PE:-626.92
High:541.000
Open:421.800
Low:421.800
Close:421.800
52wk High:541.000
52wk Low:178.000
Shares:88.88M
HK Float Shares:88.88M
Volume Ratio:4.25
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.839
ROE:-39.50%
ROA:-23.53%
PB:51.69
PE(LYR):-626.92
PS:218.56

Loading ...

Company Profile

Company Name:
DIAGENS-B
Exchange:
SEHK
Establishment Date:
2016
Employees:
174
Office Location:
Room 101,Building 1,Donghu Sub-district,Linping District,Hangzhou,Zhejiang Province,China
Zip Code:
- -
Fax:
- -
Introduction:
Hangzhou Deshi Biotechnology Co., Ltd. (hereinafter referred to as "Deshi Biotechnology") is a global leader in the fields of medical imaging AI and medical imaging equipment, with operations spanning the worldwide market. Leveraging its independently developed general-purpose medical imaging foundation model, iMedImage, the company has successfully built a diversified portfolio of intelligent imaging devices and supporting solutions, including the AutoVision Chromosome Karyotyping System, the MetaSight Automated Cell Microscopy Image Scanning System, the KayoFlow Automated Cell Harvesting and Slide Preparation–Staining Integrated System, and others—each designed to meet the diverse needs of clinical settings. The company's customer base now encompasses more than 400 healthcare centers and medical institutions across China, earning widespread market recognition. Looking ahead, Deshi Biotechnology will continue to provide global customers with standardized intelligent imaging equipment, a Model-as-a-Service (MaaS) cloud platform, and localized self-training solutions, leveraging technological innovation to enhance the efficiency, accuracy, and accessibility of medical imaging diagnostics and thereby spearheading the global medical imaging industry into the era of intelligence.

Directors

Name
Position
SONG Ning
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
WENG Zi Xin
Executive Director
XU Chen
Director,Member of the Audit Committee
WU Ling Qian
Director
YANG Ze Hao
Director
Yang Cha
Independent Director,Chairman of the Remuneration and Assessment Committee
ZHANG Jing
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Chairman of the Audit Committee
WANG Kai Feng
Independent Director,Member of the Nomination Committee,Member of the Audit Committee

Shareholders

Name
Position
SONG Ning
CEO
WANG Yang
CFO
WENG Zi Xin
COO
SHI Xin Lin
Corporate Secretary
QU Yong Shi
Corporate Secretary
GOU Zheng Meng
Other Senior Executives